부산대학교 도서관

Specenier P; Vermorken JB

Biologics: Targets & Therapy, Vol 2013, Iss default, Pp 77-90 (2013)

Limkin E; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Gustave-Roussy, Villejuif, France.; Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Gustave-Roussy, Villejuif, France; Oncostat U1018 INSERM, Labeled Ligue Contre le Cancer, Villejuif, France; Groupe d'Oncologie Radiothérapie Tête Et Cou, Tours, France. Electronic address: pierre.blanchard@gustaveroussy.fr.; Lacas B; Oncostat U1018 INSERM, Labeled Ligue Contre le Cancer, Villejuif, France; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Gustave-Roussy, Villejuif, France.; Bourhis J; Groupe d'Oncologie Radiothérapie Tête Et Cou, Tours, France; CHUV, Lausanne, Switzerland.; Parmar M; MRC Clinical Trials Unit at UCL, London, United Kingdom.; Licitra L; Fondazione IRCCS Istituto Tumori Milan and University of Milan, Italy.; Le QT; Stanford University School of Medicine, Stanford, CA, USA; NRG Oncology, Philadelphia, PA, USA.; Yom SS; NRG Oncology, Philadelphia, PA, USA.; Fortpied C; EORTC, Brussels, Belgium.; Langendijk J; University Medical Center Groningen, Groningen, Netherlands.; Vermorken JB; Antwerp University Hospital, Edegem, Belgium.; Bernier J; Clinique de Genolier, Genolier, Switzerland.; Overgaard J; Aarhus University Hospital, Aarhus, Denmark.; Harris J; NRG Oncology, Philadelphia, PA, USA.; Pignon JP; Oncostat U1018 INSERM, Labeled Ligue Contre le Cancer, Villejuif, France; Groupe d'Oncologie Radiothérapie Tête Et Cou, Tours, France; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Gustave-Roussy, Villejuif, France.; Auperin A; Oncostat U1018 INSERM, Labeled Ligue Contre le Cancer, Villejuif, France; Groupe d'Oncologie Radiothérapie Tête Et Cou, Tours, France; Department of Biostatistics and Epidemiology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Gustave-Roussy, Villejuif, France.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

Zaryouh H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; De Pauw I; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Baysal H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Melis J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Van den Bossche V; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels B-1200, Belgium.; Institut Roi Albert II, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels B-1200, Belgium.; Hermans C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Lau HW; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Lambrechts H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Merlin C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Corbet C; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels B-1200, Belgium.; Peeters M; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Department of Medical Oncology, Antwerp University Hospital, Edegem 2650, Belgium.; Vermorken JB; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Department of Medical Oncology, Antwerp University Hospital, Edegem 2650, Belgium.; De Waele J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; The authors contributed equally.; Wouters A; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; The authors contributed equally.

Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE

Szturz P; Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Lybaert W; Multidisciplinary Head and Neck Cancer Clinic at the Antwerp University Hospital (UZA) and VITAZ, Sint-Niklaas, Belgium.; Vermorken JB; Faculty of Medicine and Health Sciences, Antwerp University (UA), Antwerp, Belgium.; Department of Medical Oncology, Antwerp University Hospital (UZA), Edegem, Belgium.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Pamulapati S; Internal Medicine Program, Mercyhealth, Rockford, IL 61114, USA.; Patel B; Department of Internal Medicine, Emory University, Atlanta, GA 30307, USA.; Mody M; Hematology and Oncology Program, AdventHealth Medical Group, Calhoun, GA 30701, USA.; Strojan P; Department of Radiation Oncology, Institute of Oncology, 1000 Ljubljana, Slovenia.; Takes R; Department of Otolaryngology and Head and Neck Surgery, Radboud University Medical Center, 6525 Nijmegen, The Netherlands.; Mäkitie AA; Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, Research Program in Systems Oncology, FI-00014 Helsinki, Finland.; Cohen O; Department of Otolaryngology, Ben Gurion University of the Negev, Soroka Medical Center, Be'er Sheva 84-101, Israel.; Pace-Asciak P; Department of Otolarynology-Head and Neck Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada.; Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, 2650 Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.; Bradford C; Department of Otolaryngology, The Ohio State University, Columbus, OH 43212, USA.; Forastiere A; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.; Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.; Wieland A; Department of Otolaryngology, The Ohio State University, Columbus, OH 43212, USA.; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.; Ferlito A; Coordinator of the International Head and Neck Scientific Group, 35100 Padua, Italy.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Cossu Rocca M; European Institute of Oncology, IRCCS, Milan, Italy. maria.cossurocca@ieo.it.; Lorini L; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.; Szturz P; Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Bossi P; Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili, 25123, Brescia, Italy.; Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1969 (Electronic) Linking ISSN: 1170229X NLM ISO Abbreviation: Drugs Aging Subsets: MEDLINE

Szturz P; Medical Oncology, Department of Oncology, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland.; Faculty of Biology and Medicine, University of Lausanne (UNIL), 1011 Lausanne, Switzerland.; Bonomo P; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy.; Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, 2650 Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Zaryouh H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Antwerp, Belgium.; Van Loenhout J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Antwerp, Belgium.; Peeters M; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Antwerp, Belgium.; Department of Medical Oncology, Antwerp University Hospital, 2650 Edegem, Belgium.; Vermorken JB; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Antwerp, Belgium.; Department of Medical Oncology, Antwerp University Hospital, 2650 Edegem, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Antwerp, Belgium.; Wouters A; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Antwerp, Belgium.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Baysal H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Siozopoulou V; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Pathology, Antwerp University Hospital, Antwerp, Belgium.; Zaryouh H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Hermans C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Lau HW; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Lambrechts H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Fransen E; StatUa, University of Antwerp, Antwerp, Belgium.; De Pauw I; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Jacobs J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Peeters M; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Oncology, Antwerp University Hospital, Antwerp, Belgium.; Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Pathology, Antwerp University Hospital, Antwerp, Belgium.; Vermorken JB; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Oncology, Antwerp University Hospital, Antwerp, Belgium.; Smits E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; De Waele J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Wouters A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE